EGFRvIII Peptide

A synthetic peptide sequence derived from the tumor specific mutant variant of epidermal growth factor receptor EGFRvIII originally found in… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

2004-2012
0120042012

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Glioblastoma, the most common primary malignant brain tumor, is among the most difficult cancers to treat. Despite the aggressive… (More)
Is this relevant?
2012
2012
Three different synthetic strategies were tested to synthesize EGFRvIII peptide (1), which is a functional variant of the… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
2006
2006
2529 Background: Despite multimodality approaches, survival with GBM is dismal. Induction of immune responses to suppress the… (More)
Is this relevant?
2005
2005
The type III variant of the epidermal growth factor receptor (EGFRvIII) mutation is present in 20–25% of patients with… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2004
2004
EGFRvIII is the type III deletion mutant form of the epidermal growth factor receptor (EGFR) with transforming activity. This… (More)
Is this relevant?